Freed Investment is an investment fund managing more than $131 million ran by Kenneth Freed. There are currently 15 companies in Mr. Freed’s portfolio. The largest investments include Fidelity Comwlth Tr and Ishares Tr, together worth $82.4 million.
As of 8th November 2021, Freed Investment’s top holding is 777,052 shares of Fidelity Comwlth Tr currently worth over $43.7 million and making up 33.3% of the portfolio value.
In addition, the fund holds 90,048 shares of Ishares Tr worth $38.8 million.
The third-largest holding is Apple Inc worth $8.38 million and the next is Amazon.com worth $7.27 million, with 2,213 shares owned.
Currently, Freed Investment's portfolio is worth at least $131 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Freed Investment office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Kenneth Freed serves as the Chief Compliance Officer at Freed Investment.
In the most recent 13F filing, Freed Investment revealed that it had opened a new position in
Pmv Pharmaceuticals Inc and bought 24,880 shares worth $741 thousand.
This means they effectively own approximately 0.1% of the company.
Pmv Pharmaceuticals Inc makes up
53.0%
of the fund's Health Care sector allocation and has decreased its share price by approximately 0.1% in the past year.
The investment fund also strengthened its position in Fidelity Comwlth Tr by buying
2,737 additional shares.
This makes their stake in Fidelity Comwlth Tr total 777,052 shares worth $43.7 million.
On the other hand, Kenneth Freed disclosed a decreased stake in Amazon.com by approximately 0.1%.
This leaves the value of the investment at $7.27 million and 2,213 shares.
The two most similar investment funds to Freed Investment are Petix & Botte Co and Eos Focused Equity Management, L.P.. They manage $131 million and $131 million respectively.
Freed Investment’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Technology — making up 13.9% of
the total portfolio value.
The fund focuses on investments in the United States as
66.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
40% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $833 billion.
These positions were updated on November 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Fidelity Comwlth Tr |
0.35%
777,052
|
$43,655,000 | 33.28% |
| Ishares Tr |
2.35%
90,048
|
$38,794,000 | 29.57% |
| Apple Inc |
4.39%
59,199
|
$8,377,000 | 6.39% |
| Amazon.com Inc. |
0.54%
2,213
|
$7,270,000 | 5.54% |
| Microsoft Corporation |
0.88%
24,979
|
$7,042,000 | 5.37% |
| Spdr Dow Jones Indl Average |
5.56%
20,523
|
$6,943,000 | 5.29% |
| Visa Inc |
0.75%
25,902
|
$5,770,000 | 4.40% |
| Alphabet Inc |
0.05%
3,944
|
$10,528,000 | 8.03% |
| Pmv Pharmaceuticals Inc |
Opened
24,880
|
$741,000 | 0.56% |
| NVIDIA Corp |
300.00%
2,996
|
$621,000 | 0.47% |
| Johnson Johnson |
No change
3,259
|
$526,000 | 0.40% |
| Codiak BioSciences, Inc. |
No change
20,328
|
$332,000 | 0.25% |
| Spdr Sp 500 Etf Tr |
1.93%
610
|
$262,000 | 0.20% |
| Vir Biotechnology Inc |
No change
5,000
|
$218,000 | 0.17% |
| Citius Pharmaceuticals Inc |
Opened
52,900
|
$107,000 | 0.08% |
| No transactions found | |||
| Showing first 500 out of 15 holdings | |||